Index
Module 16 • Shock & Hemodynamics
Shock Syndromes II
41%
Data Tables
Shock Syndromes II
Mahmoud A. Ammar ~3 min read Module 16 of 20
22
/ 54

Shock Syndromes II

Patient Case

Questions 3 and 4 pertain to the following case.

D.R. is a 37-year-old man with an unknown medical history who presents after a helmeted motorcycle collision

into a deer. On primary survey, his endotracheal tube is secured, respiratory rate is 37 breaths/minute, SBP is 72

mm Hg, heart rate is 141 beats/minute, and Glasgow Coma Scale score is 5T. His FAST examination is positive.

An MTP is initiated, and the patient is taken to the operating room for an emergency exploratory laparotomy.

3

Which is the best initial resuscitation strategy to manage his hypotension?

A.Initiate a sodium chloride (0.9%) 3000-mL bolus to maintain a MAP over 65 mm Hg.
B.Obtain an Hgb concentration to guide erythrocyte transfusions, with goal Hgb 7–9 g/dL.
C.Initiate a norepinephrine infusion to maintain an SBP goal of 80–90 mm Hg.
D.Initiate PBRCs, plasma, and platelets in a 1:1:1 ratio on the basis of clinical examination.
4

In the operating room, the patient is found to have grade 5 hepatic laceration and grade IV spleen injury

status after perihepatic packing and splenectomy. His abdomen is left open with a wound vacuum-assisted

closure, and he is taken to the ICU. On arrival to the ICU (5 hours after injury), an arterial blood gas reveals

a pH 7.18, partial pressure of carbon dioxide 22 mm Hg, lactate 12.7 g/dL, and Pao2 of 86% on 40% Fio2

with assist control ventilation. He has received 14 units of erythrocytes, 12 units of plasma, and 12 units of

platelets. His laboratory values include aPTT 37 seconds, INR 1.3, Hgb 7.5 g/dL, and Plt 154,000/mm3. His

temperature is 99Β°F (37.2Β°C) and ionized calcium is 0.7 mmol/L. Which is the best pharmacologic treatment

strategy to manage his ongoing hemorrhagic shock in a goal-directed fashion?

A.Infuse 150 mEq of sodium bicarbonate in 1 L of sterile water at 200 mL/hour.
B.Give 1 g of calcium chloride once infused over 1 hour.
C.Give rFVIIa 90 mcg/kg once intravenous push.
D.Give a tranexamic acid 1000-mg bolus and 1000 mg infused over 8 hours.
L.Reversal of Oral Anticoagulant Agents (Table 6)
1

Patient selection

Assessment of bleed severity in patients treated with oral anticoagulants is critical to guide

decisions related to reversal.

The American College of Cardiology (ACC) 2020 expert consensus decision pathway suggests

consideration for anticoagulation reversal in a major bleed, generally defined as bleeding into a

critical site, hemodynamic instability, or clinically overt bleeding.

Critical bleed site:

(a)Bleeding in a critical site can compromise the organ function, may cause severe disability,

and can potentially require surgical intervention.

(b)These sites include: intracranial, other central nervous system (spinal, ocular), thoracic

(e.g., pericardial tamponade, hemothorax), intra-abdominal, retroperitoneal, airway

bleeding associated with respiratory distress, or extremity bleeding (e.g., intraarticular,

intramuscular) causing compartment syndrome

(c)Intraluminal GI bleeding is not considered a critical site; however, GI bleeding may be

considered a major bleed on the basis of hemodynamic or overt bleeding criteria.

HD Video Explanation β€” Synchronized with PDF
Starts at: minute 21 Open on YouTube